GetTopicDetailResponse(id=e6445820e1d, topicName=新型口服抗凝劑, introduction=新型口服抗凝劑, content=null, image=null, comments=1, allHits=1375, url=https://h5.medsci.cn/topic?id=58207, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=8835, tagList=[TagDto(tagId=8835, tagName=新型口服抗凝劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1220319, encodeId=49bb12203190b, content=<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌癥#</a>的<a href='/topic/show?id=737a54248f5' target=_blank style='color:#2F92EE;'>#房顫#</a>患者，<a href='/topic/show?id=e6445820e1d' target=_blank style='color:#2F92EE;'>#新型口服抗凝劑#</a>還是<a href='/topic/show?id=c3cc35912aa' target=_blank style='color:#2F92EE;'>#華法林#</a>？這是好的問(wèn)題，華法林雖然，但是安全性存疑, objectTitle=Stroke：患有癌癥的房顫患者，新型口服抗凝劑還是華法林？, objectType=article, longId=221150, objectId=a014221150ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211126/1637935435585_5295905.jpg, objectUrl=/article/show_article.do?id=a014221150ad, replyNumber=0, likeNumber=220, createdTime=2022-05-17, rootId=0, userName=賽華佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a014221150ad, moduleTitle=Stroke：患有癌癥的房顫患者，新型口服抗凝劑還是華法林？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a014221150ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
